UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (Exact name of registrant as specified in its charter) | Delaware | | | 26-0199180 | | --- | --- | --- | --- | | (State or other jurisdiction of incorporation or | | | (I.R.S. Employer Identification No.) | | organization) | | | | | 900 Island Drive | Redwood City | CA | 94065 | | ( ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-K ___________________________________ (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 ___________________ ...

PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2021 Earnings Conference Call March 8, 2022 8:00 AM ET Company Participants Reza Zadno – Chief Executive Officer Matt Bacso – Gilmartin Group Kevin Waters – Chief Financial Officer Conference Call Participants Craig Bijou – Bank of America Phil Ames – Goldman Sachs Chris Pasquale – Guggenheim Anne Hite – SVB Leerink Operator Good morning, ladies and gentlemen. And welcome to PROCEPT BioRobotics Fourth-quarter earnings conference call. At this time, all participants are i ...

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Matt Bacso – Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen Amit Hazan – Goldman Sachs Chris Pasquale – Guggenheim Danielle Antalffy – SVB Leerink Operator Good afternoon, and welcome to PROCEPT BioRobotics Third Quarter Earnings Conference Call. [Operator instructions] We will be fac ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40797 PROCEPT BioRobotics Corporation (Exact name of registrant as specified in its charter) | Delaware | | | 26-0199180 | | ...